Literature DB >> 18727946

Controlled release of vitamin B2 using mesoporous materials functionalized with amine-bearing gate-like scaffoldings.

Andrea Bernardos1, Elena Aznar, Carmen Coll, Ramón Martínez-Mañez, Jose Manuel Barat, Ma Dolores Marcos, Félix Sancenón, Angel Benito, Juan Soto.   

Abstract

A study on the controlled release of vitamin B(2) in pure water from mesoporous silica-based materials containing a pH- and anion-controlled nano-supramolecular gate-like ensembles built up by anchoring suitable polyamines on the external surface is reported (solid S1). This solid contains the vitamin (the delivered molecule) onto the pores, whereas the amine-based gate-like ensemble is anchored on the pore outlets. To obtain solid S1 the mesoporous MCM-41 support was first synthesized using tetraethyl orthosilicate (TEOS) as hydrolytic inorganic precursor and the surfactant hexadecyltrimethylammonium bromide (CTAB) as porogen species. Calcination of the mesostructured phase resulted in the starting solid. Then, first the vitamin and the latter an excess of 3-[2-(2-aminoethylamino)ethylamino]propyl-trimethoxysilane were added to the suspension containing the MCM-41 scaffolding and stirred. Solid S1 was characterized using standard solid state procedures. It was found that the functionalization process and the inclusion of the vitamin on the pores do not modify the mesoporous structure of the starting material. Delivery studies in water were carried out at pH 2 and 7. At pH 2 all the anions studied (sulfate, phosphate, GMP and ATP) strongly hinder vitamin release (C(anion)=1 x 10(-2) mol dm(-3)), whereas at pH 7 the delivery was observed for sulfate and GMP whereas the gate remained closed in the presence of ATP and phosphate. Selective delivery at neutral pH and no-liberation in acidic conditions can also be controlled with ATP and GMP using a suitable concentration of anion. The remarkable anion-controllable response of the gate-like ensemble at a certain pH can be explained in terms of anion complex formation with the tethered polyamines. Finally, selectivity patterns have been discussed in terms of kinetic rates of vitamin B(2) release. The pH-controlled gate-like scaffoldings on S1 might be a suitable prototype for the development of orally applicable delivery systems designed to have the particular ability to protect the cargo from the acidic conditions of the stomach (acid pH, gate closed) but will release the load at the intestine (basic pH, gate open).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18727946     DOI: 10.1016/j.jconrel.2008.07.037

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  5 in total

1.  Mesoporous silica nanoparticles equipped with surface nanovalves for pH-controlled liberation of doxorubicin.

Authors:  N V Roik; L A Belyakova
Journal:  Interface Focus       Date:  2016-12-06       Impact factor: 3.906

2.  Immobilization of Zidovudine Derivatives on the SBA-15 Mesoporous Silica and Evaluation of Their Cytotoxic Activity.

Authors:  Dawid Lewandowski; Marta Lewandowska; Piotr Ruszkowski; Anita Pińska; Grzegorz Schroeder
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

3.  Enhanced antifungal efficacy of tebuconazole using gated pH-driven mesoporous nanoparticles.

Authors:  Núria Mas; Irene Galiana; Silvia Hurtado; Laura Mondragón; Andrea Bernardos; Félix Sancenón; María D Marcos; Pedro Amorós; Nuria Abril-Utrillas; Ramón Martínez-Máñez; José Ramón Murguía
Journal:  Int J Nanomedicine       Date:  2014-05-23

4.  Antibody-capped mesoporous nanoscopic materials: design of a probe for the selective chromo-fluorogenic detection of finasteride.

Authors:  Estela Climent; Ramón Martínez-Máñez; Angel Maquieira; Félix Sancenón; M Dolores Marcos; Eva M Brun; Juan Soto; Pedro Amorós
Journal:  ChemistryOpen       Date:  2012-10-24       Impact factor: 2.911

5.  Lactose-Gated Mesoporous Silica Particles for Intestinal Controlled Delivery of Essential Oil Components: An In Vitro and In Vivo Study.

Authors:  Elisa Poyatos-Racionero; Isabel González-Álvarez; Paola Sánchez-Moreno; Leopoldo Sitia; Francesca Gatto; Pier Paolo Pompa; Elena Aznar; Marta González-Álvarez; Ramón Martínez-Máñez; María Dolores Marcos; Andrea Bernardos
Journal:  Pharmaceutics       Date:  2021-06-29       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.